Synthesis, DNA-binding activity and cytotoxicity of carbamate derivatives of Hoechst 33258 in breast cancer MCF-7 cells

被引:11
作者
Bielawski, K
Bielawska, A
Wolczynski, S
机构
[1] Med Acad Bialystok, Dept Med Chem & Drug Technol, PL-15230 Bialystok, Poland
[2] Med Acad Bialystok, Dept Gynecol Endocrinol, PL-15276 Bialystok, Poland
关键词
Hoechst; 33258; DNA-binding; ultrafiltration assay; breast cancer MCF-7 cell;
D O I
10.1248/bpb.25.916
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A series of carbamate derivatives of Hoechst 33258 was prepared as potential anticancer agents. These new compounds (1-4) were readily prepared in good yields by addition of chloroethyl, bromoethyl, chloropropyl or 4-(chloromethyl)phenyl isocyanates to Hoechst 33258. Their cytotoxic activity was evaluated on human breast cancer MCF-7. Compounds 1-4 were more cytotoxic than Hoechst 33258. In particular derivative 4, the most active of the series, is up to 3 times more potent than Hoechst 33258. The DNA-binding ability of these compounds was evaluated by an ultrafiltration method using calf thymus DNA. These data show that in broad terms the cytotoxic potency of 1-4 in cultured breast cancer MCF-7 cells increases, in accord with their increases in DNA affinity, as shown by the binding constant values.
引用
收藏
页码:916 / 919
页数:4
相关论文
共 19 条
[1]   THE DIFFERENT BINDING MODES OF HOECHST-33258 TO DNA STUDIED BY ELECTRIC LINEAR DICHROISM [J].
BAILLY, C ;
COLSON, P ;
HENICHART, JP ;
HOUSSIER, C .
NUCLEIC ACIDS RESEARCH, 1993, 21 (16) :3705-3709
[2]   DNA-Binding activity and cytotoxicity of the extended diphenylfuran bisamidines in breast cancer MCF-7 cells [J].
Bielawski, K ;
Wolczynski, S ;
Bielawska, A .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (06) :704-706
[3]  
CARMICHAEL J, 1987, CANCER RES, V47, P936
[4]  
Denny WA, 2001, CURR MED CHEM, V8, P533
[5]   STRUCTURE, DNA MINOR-GROOVE BINDING, AND BASE-PAIR SPECIFICITY OF ALKYL-LINKED AND ARYL-LINKED BIS(AMIDINOBENZIMIDAZOLES) AND BIS(AMIDINOINDOLES) [J].
FAIRLEY, TA ;
TIDWELL, RR ;
DONKOR, I ;
NAIMAN, NA ;
OHEMENG, KA ;
LOMBARDY, RJ ;
BENTLEY, JA ;
CORY, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (12) :1746-1753
[6]  
Fukutomi R, 1996, CHEM PHARM BULL, V44, P1983
[7]   Quantitative structure-activity relationships on 5-substituted terbenzimidazoles as topoisomerase I poisons and antitumor agents [J].
Kim, JS ;
Sun, Q ;
Yu, C ;
Liu, A ;
Liu, LF ;
LaVoie, EJ .
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (02) :163-172
[8]  
KRAUT EH, 1991, INVEST NEW DRUG, V9, P95
[9]   A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity [J].
Mann, J ;
Baron, A ;
Opoku-Boahen, Y ;
Johansson, E ;
Parkinson, G ;
Kelland, LR ;
Neidle, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (02) :138-144
[10]  
Moon JH, 1996, BIOPOLYMERS, V38, P593, DOI 10.1002/(SICI)1097-0282(199605)38:5<593::AID-BIP5>3.3.CO